Table 3.
Outcomes and Complications After BAV
| Overall (n=127) |
|
|---|---|
| 1-year mortality | |
| All-cause mortality | 41 (32.3) |
| Cardiovascular death | 8 (6.3) |
| Pneumonia | 12 (9.4) |
| Sepsis (cholecystitis, arthritis) | 3 (2.4) |
| Cancer | 3 (2.4) |
| GI bleeding | 2 (1.6) |
| Unknown (decrepitude) | 7 (5.5) |
| In-hospital mortality | |
| All-cause mortality | 14 (11.0) |
| Cardiovascular death | 3 (2.4) |
| Pneumonia | 3 (2.4) |
| Sepsis (cholecystitis, arthritis) | 1 (0.8) |
| Cancer | 0 (0.0) |
| GI bleeding | 0 (0.0) |
| Unknown (decrepitude) | 0 (0.0) |
| 30-day mortality | |
| All-cause mortality | 14 (11.0) |
| Cardiovascular death | 4 (3.1) |
| Pneumonia | 2 (1.6) |
| Sepsis (cholecystitis, arthritis) | 1 (0.8) |
| Cancer | 0 (0.0) |
| GI bleeding | 0 (0.0) |
| Unknown (decrepitude) | 0 (0.0) |
| Complications | |
| Bleeding | 2 (1.6) |
| Symptomatic stroke | 2 (1.6) |
| Cardiac tamponade | 4 (3.1) |
| AR | 1 (0.8) |
Data given as n (%). GI, gastrointestinal. Other abbreviations as in Table 2.